Gene Query: VAMP2

Dataset Description Geneva Score
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 56.12
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 51.19
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 42.26
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 36.89
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 36.49
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 32.76
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 31.38
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 30.11
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 25.61
Argonaute proteins couple chromatin silencing to alternative splicing 24.72
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 24.72
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 24.69
Examining serotonergic neuron differentiation from human iPSCs 24.61
Cleavage Factor Im as a key regulator of 3’ UTR length 23.66
circRNA-sequencing 23.04
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 21.14
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 21.08
Landscape of H3K4me3 in human CD19 cells 20.92
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 20.07
Alteration of the microRNA network during the progression of Alzheimer’s disease 19.45
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 18.96
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 17.57
A Unique Epigenomic Landscape Defines Human Erythropoiesis 17.55
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 17.55
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 17.48
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 17.23
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 17.23
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 16.88
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 16.69
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 16.18
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 15.45
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 15.43
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 15.28
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 15.16
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 14.98
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 14.86
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 14.86
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 14.57
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 14.53
A549 cells and MSR-A549 cells 14.53
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 14.38
Effect of Influenza virus infection on lncRNA expression in A549 cells 14.27
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 14.17
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 14.17
Impact of dieldrin on transcription in Jurkat T cells 14.05
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 13.58
Gene expression changes after LOC550643 silencing 13.44
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 13.4
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 13.24
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 13.16
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 13.16
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 13.11
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 12.75
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 12.64
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 12.61
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 12.6
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 12.6
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 12.26
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 12.15
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 12.02
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 12.02
Intrahepatic MAIT cell gene expression revealed by RNA-seq 11.9
Pancreatic cancer-derived exosomes induce apoptosis of T lymphocytes through the p38 MAPK signal transduction pathway 11.89
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 11.8
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 11.77
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 11.72
The role of FAM46C in myeloma cells 11.63
The role of FAM46C in myeloma cells [sequencing] 11.63
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 11.58
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 11.32
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 11.29
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 11.22
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 11.2
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 11.09
Epigenomic landscape during organ formation in human early embryos 11.0
The effect of insulin on mRNA transcription of human pluripotent stem cells 10.97
miRNAs affected by antagomiR-17 treatment 10.9
Expression and functions of long noncoding RNAs during human T helper cell differentiation 10.9
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 10.84
The regulartory role of ZCCHC24 in splicing machinery 10.8
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 10.76
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 10.72
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 10.63
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 10.62
Mutational landscape of splicing genes and functional consequences across 33 cancer types 10.61
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 10.61
Hsa-miR-371a-5p and hsa-miR-518a-3p regulated genes in choriocarcinoma cells 10.61
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 10.6
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 10.54
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 10.53
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 10.39
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 10.39
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 10.36
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 10.31
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 10.23
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 10.23
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 10.22
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 10.21
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 10.21
RNA-seq and Microarray in Transcriptome Profiling of Anterior Cruciate Ligament Tears: Implications for Prognostic Biomarkers Discovery 10.17
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 10.1
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 10.04
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 10.02
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 10.02
Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits 9.98
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 9.97
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 9.97
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 9.97
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 9.97
Genome wide expression change by RNF168 knocking down in NEC cells 9.95
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 9.94
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 9.89
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 9.76
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 9.69
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 9.63
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 9.61
Lysine benzoylation is a novel histone mark 9.61
Lysine benzoylation is a novel histone mark [RNA-seq] 9.61
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 9.59
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 9.57
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 9.56
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 9.52
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 9.51
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 9.51
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 9.43
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 9.43
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 9.4
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 9.26
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 9.26
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 9.26
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 9.25
IDH3a KO RNA-seq 9.24
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 9.17
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 9.17
CROP-Seq in Primary Human T Cells 9.08
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 9.07
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 9.05
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 9.05
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 9.02
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 9.0
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.9
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 8.78
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 8.71
Overexpression of NFIB and YBX1 in MCF-7 cells 8.7
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 8.64
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 8.64
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 8.6
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 8.58
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 8.55
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 8.55
Transcriptome of activated human and mouse MAIT cells 8.54
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 8.53
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 8.53
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 8.25
nELAVL HITS-CLIP in Alzheimer's Disease patients 8.2
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 8.11
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 8.1
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 8.05
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 7.97
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 7.96
Identification of renal resident macrophages across species 7.91
RNA-seq of naive and primed ES cells (NHSM) 7.89
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 7.85
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 7.81
scRNASeq analysis of cycling cardiomyocytes 7.79
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 7.77
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 7.69
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 7.67
Transcriptome of Stabilin-1 siRNA transfected human monocytes 7.64
Identification of Sin3B regulated genes during quiescence 7.6
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 7.6
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 7.6
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 7.58
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 7.54
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 7.52
MULTI-seq: Universal sample multiplexing for single-cell RNA sequencing using lipid-tagged indices 7.43
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 7.43
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 7.41
Dynamic 3D chromosomal landscapes in acute leukemia 7.41
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.41
Primary Human B-cell Temporal Response to CD40L Stimulation 7.39
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 7.39
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 7.36
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 7.33
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 7.32
RNA-Seq analysis of 4N and 2N RPE1 cells following polyploid induction via cytokinesis failure or Aurora kinase inhibition [tpo3] 7.3
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 7.28
Transcriptomic analysis of the HOTAIR-regulated genes 7.28
An integrative analysis of non-coding regulatory DNA variations associated with autism 7.28
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 7.25
AUF-1 affected genes in human skin cells 7.19
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 7.18
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 7.18
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 7.17
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 7.17
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 7.17
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 7.09
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 7.06
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 6.96
Regulation of Lipids is Central to Replicative Senescence 6.91
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 6.91
De novo reconstruction of human adipose reveals conserved lncRNAs as regulators of brown adipogenesis 6.91
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 6.87
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 6.84
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 6.74
IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis 6.73
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 6.67
Silencing SPIB in attached and floating state of H1703 lung cancer cells 6.65
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.63
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.63
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 6.59
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 6.57
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 6.57
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.57
Regulation of highly expressed hCINAP on translatome 6.53
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 6.51
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 6.49
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 6.48
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 6.46
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 6.46
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 6.41
Be1 and Be2 B cells are transcriptionally distinct 6.4
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 6.38
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.33
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 6.32
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 6.31
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.31
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 6.29
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 6.2
A practical evaluation of alignment algorithms for RNA variant calling analysis 6.19
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 6.18
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 6.18
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 6.17
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 6.12
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 6.12
Total RNA sequencing of APC mutant and wt colonic organoids 6.09
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch3] 6.07
FGF2 regulation of gene expression in stable inducible Neurons 6.06
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 6.05
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 6.05
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 6.04
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.03
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 6.02
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 5.99
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 5.99
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.97
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 5.97
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 5.97
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 5.96
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 5.92
The comparison of high-throughput single-cell RNA-seq methods 5.91
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 5.9
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 5.88
RNA-Sequencing of HUVEC treated with Tie2 activating antibody 5.84
Controlling for gene expression changes in transcription factor protein networks. 5.79
Transcriptional dependencies in diffuse intrinsic pontine glioma 5.79
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 5.79
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 5.75
A transcriptome-wide divergence in protein translation scales with LIN28B expression 5.75
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 5.73
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 5.67
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 5.66
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 5.66
Total RNA sequencing of WT intestinal orgaonids. 5.64
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 5.57
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 5.54
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 5.54
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 5.54
TT-Seq captures the human transient transcriptome 5.53
Engineering Patient-Specific Tissue Implants 5.52
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 5.52
Time-Resolved Proteomics Extends Ribosome Profiling-Based Measurements of Protein Synthesis Dynamics 5.5
Effect of PRDM11 depletion in U2932 cells 5.47
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 5.46
ENCODE Cold Spring Harbor Labs Long RNA-seq 5.46
Ambient O2 pressure induces NF-kB1/RelA related inflammatory response in human lung epithelial cells in vitro 5.46
Effect of CHKA knockdown on C4-2 cell transcriptome 5.39
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 5.39
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 5.32
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 5.3
Gene expression in GBM with Cav3.2 inhibition 5.3
Zika virus directly infects human peripheral neurons and induces cell death 5.27
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.24
Regulating Interleukin-2 activity with engineered receptor signaling clamps 5.21
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 5.21
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 5.15
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 5.12
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 5.12
Human neutrophil genome during PMA- and E. coli encounter-induced activation 5.12
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 5.07
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 5.01
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 4.99
Transcriptome analysis of kidney organoids 4.9
Trans-differentiation of human adult peripheral blood T cells into neurons 4.87
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 4.86
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.86
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.85
O-glcnAc reprograms cellular energetics 4.84
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 4.8
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 4.74
mRNA-Seq profiling of human developing kidney 4.71
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 4.7
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.69
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 4.63
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 4.58
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 4.49
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 4.45
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.41
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 4.41
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 4.41
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 4.41
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 4.4
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.26
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 4.25
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.25
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 4.18
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 4.15
CRISPR-mediated deletion of prostate cancer risk-associated CTCF loop anchors identifies repressive chromatin loops 4.14
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 4.1
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 4.08
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 4.07
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 4.06
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.02
Downregulation of DDX5/DDX17 and REST 4.01
The Cushing's disease adipose gene expression profile reveals effects of long term glucocorticoids on adipose tissue lipid, protein and glucose metabolism 3.96
Genome Wide Chromatin Mapping of accessibility (ATAC-seq) and H3K27ac histone modifications in CD56bright and CD56dim natural killer cells 3.92
Transcriptomic profile of human embryonic renal corpuscles 3.89
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.87
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 3.84
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.83
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.83
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.82
The circadian transcriptional landscape in primary human mammary epithelial cells 3.79
Expression charcaterization of an internal protocol developed to differentiate RPE cells 3.79
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 3.78
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 3.78
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.73
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.73
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.71
Unique features and clinical importance of acute alloreactive immune responses 3.66
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 3.61
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 3.6
Transcriptomic analysis of LSD1 3.59
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 3.54
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 3.54
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 3.53
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 3.53
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 3.49
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 3.47
Gene Expression Profiling of WT and KDM3A Knocked out Cell 3.47
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 3.47
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.44
Regulation of poly(A) tail and translation during the somatic cell cycle 3.33
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.31
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.31
The transcriptomic landscape of MAIT cell development in the thymus (C006 RNAseq data set) 3.31
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.29
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.26
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 3.23
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 3.22
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 3.22
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 3.14
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 3.13
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 3.05
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 3.04
Transposon-based construction of strand-specific RNA-seq libraries 2.95
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 2.95
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 2.91
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 2.87
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 2.85
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 2.85
The age and genomic integrity of neurons after cortical stroke in humans 2.82
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 2.75
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 2.75
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.74
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 2.73
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 2.73
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.71
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 2.69
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 2.69
RNAseq in Alzheimer's Disease patients 2.67
Identification of global XBP1s target gene expression in human prostate cancer cells 2.66
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 2.65
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 2.63
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 2.63
Identification of long noncoding RNAs in T-ALL cell lines 2.6
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 2.6
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.57
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 2.54
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 2.54
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 2.54
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 2.51
LINE-2 transposable elements are a source of functional human microRNAs and target sites 2.45
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.38
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.38
Transcriptomic insights into human decidual and peripheral blood CD4 T cells 2.36
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 2.35
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 2.35
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.33
Metastasis in triple-negative breast cancer 2.33
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 2.32
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.28
A549 cell transcriptome responses to infection with H7N9 influenza virus 2.27
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.27
Determining mRNA half-lives on a transcriptome-wide scale 2.22
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 2.22
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 2.2
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.17
Conservative alteration of chromosomal expression pattern across human solid tumor types 2.11
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.08
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 2.05
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 2.02
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 2.01
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 2.01
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 2.0
STX4 Over-Expression in Human islets 1.99
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.99
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.99
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.96
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.96
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 1.93
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.93
A single-cell transcriptome atlas of the human pancreas 1.89
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.87
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 1.87
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.82
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 1.81
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.8
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.71
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 1.71
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.68
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 1.68
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 1.67
Activity-dependent transcriptional changes in human neurons 1.66
Positively selected enhancer elements endow tumor cells with metastatic competence 1.64
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.62
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 1.59
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 1.59
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.56
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 1.54
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 1.5
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 1.46
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.46
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 1.43
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.32
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.32
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 1.3
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.29
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 1.25
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.24
Transcriptomes in healthy and CHB fetal hearts 1.23
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 1.22
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 1.13
Targeting MTHFD2 in Acute Myeloid Leukemia 1.11
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 1.09
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 1.09
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 1.08
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 1.01
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 1.0
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.89
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 0.84
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.81
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.81
LIN28A modulates splicing and gene expression programs in breast cancer cells 0.8
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 0.8
Repurposing of promoters and enhancers during mammalian evolution 0.79
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.77
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.74
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.74
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 0.73
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 0.67
Identification of a LIF-responsive replication-competent human β cell 0.63
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 0.62
Gene expression profile of calcified and normal tricuspid aortic valves by RNA sequencing. 0.6
SLAM-seq for K562 endogenous mRNA decay 0.58
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.54
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 0.54
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 0.49
Human Treg IFNg/IL-10 subpopulations 0.42
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.41
Gene expression activation in CLL mediated by MSCs contact 0.41
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.4
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.4
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.4
Transcriptome analysis of peripheral blood monocytes 0.38
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.33
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.32
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.26
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.23
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.22
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.21
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.21
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.21
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.18
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.13
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.1
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.1
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.09
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.01
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation